Trials / Completed
CompletedNCT03131661
A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDs
A Prospective, Observational Study, in Patients With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) According to ASAS Criteria, naïve to Conventional (cDMARDs), Targeted (tsDMARDs) and Biological DMARDs (bDMARDs) - SIRENA Study (Spondyloarthritis Italian Registry: Evidence From a National Pathway)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 351 (actual)
- Sponsor
- Janssen-Cilag S.p.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this Italian multicenter study is to collect prospective clinical data in participants with first diagnosis or confirmation diagnosis of Spondyloarthritis (SpA), according to Assessment of Spondyloarthritis classification (ASAS) criteria, in order to describe SpA characteristics and pattern of clinical presentation.
Conditions
Timeline
- Start date
- 2017-06-09
- Primary completion
- 2021-07-28
- Completion
- 2021-07-28
- First posted
- 2017-04-27
- Last updated
- 2021-09-30
Locations
25 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT03131661. Inclusion in this directory is not an endorsement.